Benustine-100 (Bendamustine Vials) 100mg

Benustine-100 (Bendamustine 100mg) is a chemotherapy medication used for treating certain cancers. This sterile vial form is stored at room temperature for convenience. A trusted option for cancer therapy regimens. Short-term use under medical supervision.

Strength

100mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Mediclone Health Care Pvt Ld

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Benustine-100 is primarily used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma. It may also be prescribed for other cancers as determined by a healthcare provider. This medication works by slowing or stopping cancer cell growth. Always follow a physician’s guidance for its application.

Side Effects

Benustine-100 may cause temporary effects such as nausea, fatigue, or lowered blood cell counts. Some users report mild discomfort during administration. These effects vary by individual and are typically monitored by a healthcare team. Hydration and rest are often recommended during treatment.

Precautions & Warnings

Handle Benustine-100 with care; avoid direct skin contact and use protective gear when preparing doses. Keep vials in their original packaging until use to maintain sterility. Store at room temperature away from moisture and heat. Discard any unused medication as directed by a healthcare professional.

Avoid Interactions

Benustine-100 may interact with other chemotherapy drugs, blood thinners, or medications affecting liver enzymes. Alcohol and certain vaccines should be avoided during treatment. Always inform your doctor about all medications and supplements in use. Regular monitoring helps manage potential interactions safely.

Frequently Asked Questions

Bendamustine is primarily used to treat certain types of cancer, including chronic lymphocytic leukemia and non-Hodgkin lymphoma.

Benustine-100 is typically administered as an intravenous infusion by a healthcare professional in a clinical setting.

No, bendamustine requires professional administration in a controlled medical environment due to its potency and need for monitoring.

Common side effects may include nausea, fatigue, and lowered blood cell counts, which are usually temporary and monitored.

Bendamustine should not be used during pregnancy unless clearly necessary, as it may harm an unborn baby.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.